Clinical Trials · NCT05424003
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- University of Virginia
- Enrollment
- 50
- Start date
- Feb 2024
- Locations
- 1 site, United States
- Primary endpoint
- Change in weight